Open-Source vs Hosted SaaS
Reproducibility, audit rights, data ownership, and the regulatory implications of choosing between open-source and hosted platforms for scientific AI.
The infrastructure question science cannot ignore
When a lab adopts an AI tool for research, it is not just choosing software. It is choosing a data governance model, a reproducibility posture, and a regulatory position. These choices compound over years — and they are significantly harder to reverse than most technical decisions.
The distinction between open-source tools and hosted SaaS platforms runs deeper than deployment preferences. It determines who controls your data, whether your analyses can be independently reproduced, and whether you can satisfy the audit requirements that funding agencies and regulatory bodies are now enforcing.
The question is not “where does the software run?” It is “who can verify what happened to your data?”
Data ownership and sovereignty
When research data enters a hosted platform, a transfer occurs. The specifics depend on the platform’s terms of service, but the fundamental dynamic is consistent: your data now resides on infrastructure you do not control, processed by code you cannot inspect, subject to policies that can change without your consent.
For most commercial applications, this tradeoff is reasonable. For scientific research — particularly research involving human subjects, proprietary sequences, or pre-publication results — it requires careful examination.
What data sovereignty means in practice
| Dimension | Open-source (self-hosted) | Hosted SaaS |
|---|---|---|
| Data location | Your infrastructure, your jurisdiction | Provider’s infrastructure, provider’s jurisdiction |
| Access control | Defined by your policies | Defined by provider’s policies + your configuration |
| Data retention | You decide what is kept and for how long | Subject to provider’s retention policies |
| Subpoena exposure | Limited to your organization | Extends to the provider’s legal jurisdiction |
| Terms of service | None — you own the software | Can change, sometimes retroactively |
| Training data usage | Impossible — the code runs locally | Varies — check the fine print carefully |
For research involving patient data under HIPAA, genomic data under GINA, or data from EU collaborators under GDPR, the distinction is not theoretical. A Business Associate Agreement with a SaaS provider is not equivalent to processing data on infrastructure you control.
If you cannot point to the specific machine where your patient data was processed, you have a compliance gap — not a feature.
Reproducibility at the infrastructure level
Scientific reproducibility requires more than sharing code and data. It requires the ability to re-execute an analysis and obtain the same results. When a critical step in your pipeline runs on a hosted platform, reproducibility depends on that platform remaining available, maintaining the same behavior, and continuing to offer the same API.
Platforms change. APIs are versioned, deprecated, and retired. Pricing models shift. Companies are acquired, pivot, or shut down. Each of these events can break the reproducibility of any analysis that depends on the platform.
The reproducibility audit
Ask these questions about any tool in your research pipeline:
-
Can I run this analysis in five years? If the tool is open-source, you can archive the exact version and its dependencies. If it is hosted, you are dependent on the provider’s continuity.
-
Can a reviewer run this analysis? If the tool requires a paid subscription, an API key, or an account, you have introduced a barrier to verification. Open-source tools can be freely obtained and run by anyone.
-
Can I determine the exact version that was used? Open-source tools have git commits, release tags, and dependency lockfiles. Hosted platforms may change behavior between API calls without notification.
-
Can I inspect the implementation? When a statistical method produces an unexpected result, can you read the source code to understand why? With open-source, yes. With hosted platforms, you are limited to documentation — which may be incomplete or outdated.
| Reproducibility factor | Open-source | Hosted SaaS |
|---|---|---|
| Version pinning | Git SHA, lockfiles, containers | API version headers (if available) |
| Long-term availability | Archived locally or on public repositories | Depends on provider business continuity |
| Reviewer access | Free, immediate | May require account, subscription, or API key |
| Implementation transparency | Full source code | Documentation only |
| Environment control | Docker, Conda, Nix — exact environment reproduction | Provider controls the environment |
The regulatory landscape is shifting
Research funding agencies are increasingly explicit about computational reproducibility requirements. The NIH’s 2025 Data Management and Sharing Policy (NOT-OD-25-132) requires detailed data management plans that address how computational analyses can be reproduced. The FDA’s guidance on AI/ML in drug development emphasizes the need for auditable, transparent algorithms. The EU AI Act classifies scientific research tools by risk level and imposes transparency requirements.
These regulations share a common thread: the expectation that computational methods can be independently verified. This expectation is significantly easier to satisfy with open-source tools than with hosted platforms.
Regulatory alignment comparison
| Requirement | Open-source posture | Hosted SaaS posture |
|---|---|---|
| NIH data sharing | Full compliance — share code, data, environment | Partial — can share data but not platform behavior |
| FDA audit trail | Git history + provenance manifests | Platform logs (if available and exportable) |
| EU AI Act transparency | Source code is the transparency | Depends on provider’s disclosure practices |
| IRB data handling | Documented, inspectable pipeline | Requires trust in provider’s security practices |
| HIPAA data processing | Your BAA, your infrastructure | Provider’s BAA, provider’s infrastructure |
The hybrid reality
In practice, most research groups use a combination of open-source and hosted tools. The critical question is not “which one should I use exclusively?” but rather “where does each approach belong in my pipeline?”
A reasonable framework:
- Data processing and analysis: Open-source tools with version pinning and provenance tracking. These steps must be reproducible and auditable.
- Literature search and brainstorming: Hosted tools are acceptable for exploratory work where the output will be verified against primary sources.
- Clinical or regulatory submissions: Open-source pipelines with full audit trails. No exceptions.
- Collaboration: Open-source tools enable collaboration across institutions without licensing barriers.
The cost of open-source is operational overhead. The cost of hosted SaaS is control. Know which cost you can afford for each part of your pipeline.
Making the transition
If your lab currently relies on hosted platforms for critical analysis steps, transitioning to open-source alternatives is not an overnight project. But it is a project worth starting, because the regulatory and reproducibility requirements are only going in one direction.
Start by auditing your pipeline: which steps depend on hosted platforms? Which of those steps produce outputs that will be published, submitted, or used for decisions? Those are the steps where open-source alternatives provide the most value.
The tools exist. The question is whether your infrastructure choices reflect the standards your science demands.
Hordago Labs builds open-source tools for biological research with full audit trails and provenance tracking. Explore our platform or learn how evidence-first workflows keep your research grounded in data.